LT - Antikūnų, kurie suriša limfocitų aktyvinimo geną-3 (LAG-3), optimizavimas ir jų panaudojimas
EN - OPTIMIZATION OF ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3), AND USES THEREOF
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 45/06 |
(2006.01) |
|
|
A61P 31/12 |
(2006.01) |
|
|
A61P 35/00 |
(2006.01) |
|
|
A61P 37/02 |
(2006.01) |
|
|
A61P 37/04 |
(2006.01) |
|
|
C07K 16/28 |
(2006.01) |
European patent
| (11) |
Number of the document |
3795592 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
20192145.9 |
|
Date of filing the European patent application |
2013-07-02 |
| (97) |
Date of publication of the European application |
2021-03-24 |
| (45) |
Date of publication and mention of the grant of the patent |
2024-07-24
|
| (46) |
Date of publication of the claims translation |
2024-09-25
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
201261667058 P |
2012-07-02
|
US |
Inventors
| (72) |
LONBERG, Nils , US
SRINIVASAN, Mohan , US
|
Grantee
| (73) |
Bristol-Myers Squibb Company ,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
| (54) |
Antikūnų, kurie suriša limfocitų aktyvinimo geną-3 (LAG-3), optimizavimas ir jų panaudojimas |
| |
OPTIMIZATION OF ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3), AND USES THEREOF |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2025-06-04 |
13 |
289.00
EUR
|
Next renewal fee
|
2026-07-02 |
